310 related articles for article (PubMed ID: 25727287)
1. NOD.H-2h4 mice: an important and underutilized animal model of autoimmune thyroiditis and Sjogren's syndrome.
Braley-Mullen H; Yu S
Adv Immunol; 2015; 126():1-43. PubMed ID: 25727287
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune manifestations in aged mice arise from early-life immune dysregulation.
Mahmoud TI; Wang J; Karnell JL; Wang Q; Wang S; Naiman B; Gross P; Brohawn PZ; Morehouse C; Aoyama J; Wasserfall C; Carter L; Atkinson MA; Serreze DV; Braley-Mullen H; Mustelin T; Kolbeck R; Herbst R; Ettinger R
Sci Transl Med; 2016 Oct; 8(361):361ra137. PubMed ID: 27798262
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice.
Braley-Mullen H; Sharp GC; Medling B; Tang H
J Autoimmun; 1999 May; 12(3):157-65. PubMed ID: 10222025
[TBL] [Abstract][Full Text] [Related]
4. Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome.
Karnell JL; Mahmoud TI; Herbst R; Ettinger R
Mol Immunol; 2014 Dec; 62(2):277-82. PubMed ID: 24907930
[TBL] [Abstract][Full Text] [Related]
5. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
6. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
7. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
Voynova E; Lefebvre F; Qadri A; Muller S
J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
[TBL] [Abstract][Full Text] [Related]
8. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
[TBL] [Abstract][Full Text] [Related]
9. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study.
Tunc R; Gonen MS; Acbay O; Hamuryudan V; Yazici H
Ann Rheum Dis; 2004 May; 63(5):575-7. PubMed ID: 15082490
[TBL] [Abstract][Full Text] [Related]
11. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
12. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
13. Sjögren's syndrome: immunological response underlying the disease.
Brayer JB; Humphreys-Beher MG; Peck AB
Arch Immunol Ther Exp (Warsz); 2001; 49(5):353-60. PubMed ID: 11798133
[TBL] [Abstract][Full Text] [Related]
14. A novel NOD-derived murine model of primary Sjögren's syndrome.
Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
[TBL] [Abstract][Full Text] [Related]
15. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
Cha S; Brayer J; Gao J; Brown V; Killedar S; Yasunari U; Peck AB
Scand J Immunol; 2004 Dec; 60(6):552-65. PubMed ID: 15584966
[TBL] [Abstract][Full Text] [Related]
16. Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjögren's syndrome.
Szyszko EA; Aqrawi LA; Jonsson R; Brokstad KA; Skarstein K
Autoimmunity; 2016; 49(1):41-9. PubMed ID: 26324998
[TBL] [Abstract][Full Text] [Related]
17. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
[TBL] [Abstract][Full Text] [Related]
18. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome.
Brayer JB; Cha S; Nagashima H; Yasunari U; Lindberg A; Diggs S; Martinez J; Goa J; Humphreys-Beher MG; Peck AB
Scand J Immunol; 2001; 54(1-2):133-40. PubMed ID: 11439159
[TBL] [Abstract][Full Text] [Related]
19. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model.
Humphreys-Beher MG; Peck AB
Arch Oral Biol; 1999 May; 44 Suppl 1():S21-5. PubMed ID: 10414851
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune B Cell Repertoire in a Mouse Model of Sjögren's Syndrome.
Sáez Moya M; Gutiérrez-Cózar R; Puñet-Ortiz J; Rodríguez de la Concepción ML; Blanco J; Carrillo J; Engel P
Front Immunol; 2021; 12():666545. PubMed ID: 33968069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
